Research News
A collaborative team from the GW School of Medicine and Health Sciences and Albert Einstein College of Medicine published on the possibility that curcumin may be a viable photoprotective adjuvant when delivered through nanoparticles,
The predoctoral NIH fellowship, also known as the Ruth L. Kirschstein Predoctoral Individual National Research Service Award, is earned by scholars based on the quality of their mentored research proposal and career development plan.
The GW Medical Faculty Associates will pilot a real-time remote monitoring tool for maternal mental health with Babyscripts, the leading virtual care platform for managing obstetrics. GW will be gathering data around the efficacy of the new tool for a focused research study.
GW researchers found low dose aspirin may reduce the need for mechanical ventilation, ICU admission and in-hospital mortality in hospitalized COVID-19 patients. Final results indicating the lung protective effects of aspirin were published today in Anesthesia & Analgesia.
The GW Department of Dermatology received a $250,000 grant from Pfizer to expand accessible teledermatology for atopic dermatitis patients in Washington, D.C.
The George Washington University announced today its participation in a Sanofi COVID-19 vaccine clinical trial. GW was selected as one of approximately 25 sites in the United States to launch a phase 2 study for its adjuvanted recombinant protein-based COVID-19 vaccine candidate.
Researchers at the George Washington University found that the majority of dermatology patients were comfortable with virtual visits as an alternative to in-person appointments.
Images that highlight the beauty and breadth of biomedical research and a passion for science at the George Washington University (GW) School of Medicine and Health Sciences (SMHS) were on display in the annual SMHS Art of Science contest.
A group of interdisciplinary researchers received more than $3.3 million in grants for their research on networks within the autonomic nervous system and therapies that may lead to new treatments for heart attack and sleep apnea.
A recent study by GW physicians on the severity of acute respiratory viral adverse events related to antirheumatic disease therapies found that some therapies may be associated with increased respiratory viral events while others don’t show increased frequency.